These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31745682)

  • 1. Calcium Salt of N-(5-Hydroxynicotinoyl)-L-Glutamic Acid Weakens Depressive-Like Behavior and Parkinsonian Syndrome in Experiment on Rodents.
    Kiselev AV; Vedenkin AS; Stovbun IS; Sergienko VI; Kalinina TS
    Bull Exp Biol Med; 2019 Nov; 168(1):48-51. PubMed ID: 31745682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments.
    Povarnina PY; Gudasheva TA; Vorontsova ON; Bondarenko NA; Seredenin SB
    Bull Exp Biol Med; 2011 Oct; 151(6):690-3. PubMed ID: 22485209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of antiparkinsonian action of the harmine hydrochloride original compound.
    Nurmaganbetov ZS; Arystan LI; Muldaeva GM; Haydargalieva LS; Adekenov SM
    Pharmacol Rep; 2019 Dec; 71(6):1050-1058. PubMed ID: 31605892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
    Khisti RT; Mandhane SN; Chopde CT
    Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Luthra PM; Barodia SK; Raghubir R
    J Neurosci Methods; 2009 Apr; 178(2):284-90. PubMed ID: 19146880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
    Lebsanft HB; Kohles T; Kovar KA; Schmidt WJ
    Synapse; 2005 Mar; 55(3):148-55. PubMed ID: 15602749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
    Ossowska K; Konieczny J; Wolfarth S; Pilc A
    Neuropharmacology; 2005 Sep; 49(4):447-55. PubMed ID: 15919101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models.
    Valdman E; Kapitsa I; Ivanova Е; Voronina TI; Ardashov O; Volcho K; Khazanov V; Salakhutdinov N
    Eur J Pharmacol; 2017 Nov; 815():351-363. PubMed ID: 28939292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test.
    Sartim AG; Brito BM; Gobira PH; Joca SRL
    Behav Pharmacol; 2019 Feb; 30(1):59-66. PubMed ID: 30299277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant Potential of (
    Fukumoto K; Toki H; Iijima M; Hashihayata T; Yamaguchi JI; Hashimoto K; Chaki S
    J Pharmacol Exp Ther; 2017 Apr; 361(1):9-16. PubMed ID: 28115553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.
    Steece-Collier K; Chambers LK; Jaw-Tsai SS; Menniti FS; Greenamyre JT
    Exp Neurol; 2000 May; 163(1):239-43. PubMed ID: 10785463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR55: A therapeutic target for Parkinson's disease?
    Celorrio M; Rojo-Bustamante E; Fernández-Suárez D; Sáez E; Estella-Hermoso de Mendoza A; Müller CE; Ramírez MJ; Oyarzábal J; Franco R; Aymerich MS
    Neuropharmacology; 2017 Oct; 125():319-332. PubMed ID: 28807673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol-induced parkinsonism is attenuated by varenicline in mice.
    Sharma AK; Gupta S; Patel RK; Wardhan N
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):395-401. PubMed ID: 29634484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of antidepressants with antiparkinsonian agents in rats.
    Zebrowska-Lupina I; Porowska A; Pietrasiewicz T
    Pol J Pharmacol Pharm; 1985; 37(6):865-74. PubMed ID: 3832020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptors and depression.
    El Yacoubi M; Costentin J; Vaugeois JM
    Neurology; 2003 Dec; 61(11 Suppl 6):S82-7. PubMed ID: 14663017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism.
    Beurrier C; Lopez S; Révy D; Selvam C; Goudet C; Lhérondel M; Gubellini P; Kerkerian-LeGoff L; Acher F; Pin JP; Amalric M
    FASEB J; 2009 Oct; 23(10):3619-28. PubMed ID: 19525404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter.
    Lin SH; Chou ML; Chen WC; Lai YS; Lu KH; Hao CW; Sheen LY
    J Ethnopharmacol; 2015 Dec; 175():266-72. PubMed ID: 26408043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antiparkinsonic activity of panavir on a model of Parkinson syndrome induced by systemic administration of MPTP to outbred rats and C57Bl/6 mice.
    Kalinina TS; Nerobkova LN; Voronina TA; Stovbun SV; Litvin AA; Sergienko VI
    Bull Exp Biol Med; 2005 Jul; 140(1):55-7. PubMed ID: 16254620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
    Liu Y; Ding XF; Wang XX; Zou XJ; Li XJ; Liu YY; Li J; Qian XY; Chen JX
    BMC Complement Altern Med; 2019 Aug; 19(1):215. PubMed ID: 31412844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mexidol potentiates antiparkinsonian effect of L-DOPA in MPTP-induced parkinsonism model].
    Kucherianu VG
    Eksp Klin Farmakol; 2001; 64(1):22-5. PubMed ID: 11544797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.